BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16888242)

  • 1. FHL2/SLIM3 decreases cardiomyocyte survival by inhibitory interaction with sphingosine kinase-1.
    Sun J; Yan G; Ren A; You B; Liao JK
    Circ Res; 2006 Sep; 99(5):468-76. PubMed ID: 16888242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of four-and-a-half LIM domain protein-2 increases survival, migratory capacity, and paracrine function of human early outgrowth cells through activation of the sphingosine kinase-1 pathway: implications for endothelial regeneration.
    Ebrahimian T; Arfa O; Simeone S; Lemarié CA; Lehoux S; Wassmann S
    Circ Res; 2014 Jan; 114(1):114-23. PubMed ID: 24084691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes.
    Purcell NH; Darwis D; Bueno OF; Müller JM; Schüle R; Molkentin JD
    Mol Cell Biol; 2004 Feb; 24(3):1081-95. PubMed ID: 14729955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1.
    Hayashi H; Nakagami H; Takami Y; Koriyama H; Mori M; Tamai K; Sun J; Nagao K; Morishita R; Kaneda Y
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):909-14. PubMed ID: 19325137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four-and-a-half LIM domain protein 2 is a novel regulator of sphingosine 1-phosphate receptor 1 in CCL19-induced dendritic cell migration.
    König K; Diehl L; Rommerscheidt-Fuss U; Golletz C; Quast T; Kahl P; Kolanus W; Knolle P; Buettner R; Heukamp LC
    J Immunol; 2010 Aug; 185(3):1466-75. PubMed ID: 20592280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of the expression of FHL2 by RNA interference].
    Wang ZY; Zhou L; Ding LH; Lv QJ; Yang X; Ye QN
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Nov; 26(11):1149-51. PubMed ID: 21055355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2.
    Nair SS; Guo Z; Mueller JM; Koochekpour S; Qiu Y; Tekmal RR; Schüle R; Kung HJ; Kumar R; Vadlamudi RK
    Mol Endocrinol; 2007 Mar; 21(3):613-24. PubMed ID: 17192406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four-and-a-half LIM domains proteins are novel regulators of the protein kinase D pathway in cardiac myocytes.
    Stathopoulou K; Cuello F; Candasamy AJ; Kemp EM; Ehler E; Haworth RS; Avkiran M
    Biochem J; 2014 Feb; 457(3):451-61. PubMed ID: 24219103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The LIM-only proteins FHL2 and FHL3 interact with alpha- and beta-subunits of the muscle alpha7beta1 integrin receptor.
    Samson T; Smyth N; Janetzky S; Wendler O; Müller JM; Schüle R; von der Mark H; von der Mark K; Wixler V
    J Biol Chem; 2004 Jul; 279(27):28641-52. PubMed ID: 15117962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells.
    Berdyshev EV; Gorshkova IA; Usatyuk P; Zhao Y; Saatian B; Hubbard W; Natarajan V
    Cell Signal; 2006 Oct; 18(10):1779-92. PubMed ID: 16529909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of four-and-a-half LIM 2 decreases bone mineral content and bone mineral density in femur and tibia bones of female mice.
    Govoni KE; Baylink DJ; Chen J; Mohan S
    Calcif Tissue Int; 2006 Aug; 79(2):112-7. PubMed ID: 16927043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced expression of FHL2 leads to abnormal myelopoiesis in vivo.
    Qian Z; Mao L; Fernald AA; Yu H; Luo R; Jiang Y; Anastasi J; Valk PJ; Delwel R; Le Beau MM
    Leukemia; 2009 Sep; 23(9):1650-7. PubMed ID: 19369964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of myocardin factor protein stability by the LIM-only protein FHL2.
    Hinson JS; Medlin MD; Taylor JM; Mack CP
    Am J Physiol Heart Circ Physiol; 2008 Sep; 295(3):H1067-H1075. PubMed ID: 18586895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine kinase 1 is up-regulated in colon carcinogenesis.
    Kawamori T; Osta W; Johnson KR; Pettus BJ; Bielawski J; Tanaka T; Wargovich MJ; Reddy BS; Hannun YA; Obeid LM; Zhou D
    FASEB J; 2006 Feb; 20(2):386-8. PubMed ID: 16319132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine kinase 1 protects against renal ischemia-reperfusion injury in mice by sphingosine-1-phosphate1 receptor activation.
    Park SW; Kim M; Kim M; D'Agati VD; Lee HT
    Kidney Int; 2011 Dec; 80(12):1315-27. PubMed ID: 21849969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The LIM-only protein FHL2 interacts with beta-catenin and promotes differentiation of mouse myoblasts.
    Martin B; Schneider R; Janetzky S; Waibler Z; Pandur P; Kühl M; Behrens J; von der Mark K; Starzinski-Powitz A; Wixler V
    J Cell Biol; 2002 Oct; 159(1):113-22. PubMed ID: 12370240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HSP-70 mitigates LPS/SKI-induced cell damage by increasing sphingosine kinase 1 (SK1).
    Ding XZ; Feng XR; Borschel RH; Nikolich MP; Feng J; Li YS; Hoover DL
    Prostaglandins Other Lipid Mediat; 2010 Jun; 92(1-4):1-7. PubMed ID: 20123033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency in the LIM-only protein Fhl2 impairs skin wound healing.
    Wixler V; Hirner S; Müller JM; Gullotti L; Will C; Kirfel J; Günther T; Schneider H; Bosserhoff A; Schorle H; Park J; Schüle R; Buettner R
    J Cell Biol; 2007 Apr; 177(1):163-72. PubMed ID: 17420295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-protein interaction of FHL3 with FHL2 and visualization of their interaction by green fluorescent proteins (GFP) two-fusion fluorescence resonance energy transfer (FRET).
    Li HY; Ng EK; Lee SM; Kotaka M; Tsui SK; Lee CY; Fung KP; Waye MM
    J Cell Biochem; 2001; 80(3):293-303. PubMed ID: 11135358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel colon cancer gene therapy using rAAV‑mediated expression of human shRNA-FHL2.
    Wu Y; Guo Z; Zhang D; Zhang W; Yan Q; Shi X; Zhang M; Zhao Y; Zhang Y; Jiang B; Cheng T; Bai Y; Wang J
    Int J Oncol; 2013 Nov; 43(5):1618-26. PubMed ID: 24008552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.